StemRad Scientific Advisory Board member Prof. Michael Levitt wins the Nobel Prize in Chemistry for the development of multiscale models for complex chemical systems.
StemRad appoints world-renowned health physicist and former IRPA (International Radiation Protection Association) President Prof. Kenneth R. Kase, Ph.D., to its Scientific Advisory Board.
StemRad appoints Yale Prof. Joseph Schlessinger, Ph.D., to its Board of Directors. Dr. Schlessinger is one of the world’s leading cellular biologists and a pioneer in cancer treatment, having developed three revolutionary drugs from inception, through FDA approval and on to bedside.
StemRad completes development of its revolutionary StemRad 360 Gamma PPE.
StemRad appoints 2004 Nobel Prize winner Professor Aaron J. Ciechanover, from the Technion – Israel Institute of Technology, to its Scientific Advisory Board. Prof. Ciechanover is an international leader in the field of biochemistry, with a research focus on intracellular protein degradation and mechanisms of cancer.
StemRad appoints 2006 Nobel Prize winner Professor Roger D. Kornberg, from Stanford University School of Medicine, to its Scientific Advisory Board. Prof. Kornberg is a world renowned leader in the field of biochemistry, and will play an important role in guiding StemRad’s research and development programs.